IIPLA News
Thursday, April 30, 2026

Turkish Courts Invalidate Bad Faith 'Clindoxyl' Trademark Registration in Favor of GSK

GSK secures decisive legal victory as Turkish judiciary upholds invalidation of opportunistic trademark registration, reinforcing protections for genuine rights holders.

IIPLA News Deskanonymous access0 articles left this week
Turkish Courts Invalidate Bad Faith 'Clindoxyl' Trademark Registration in Favor of GSK
Sign In To Continue

You have reached the guest article limit.

Unlock more of the IIPLA newsroom by signing in with SSO or joining as a member.

GlaxoSmithKline (GSK) has prevailed in a significant trademark dispute in Türkiye, where courts found that a third party acted in bad faith by registering the 'Clindoxyl' mark after GSK's original registration lapsed. The Turkish judiciary, including the Court of Cassation, confirmed the invalidation of the defendant'…
Share This Article
Ready-to-post copy includes the article link.

Turkish Courts Invalidate Bad Faith 'Clindoxyl' Trademark Registration in Favor of GSK GlaxoSmithKline (GSK) has prevailed in a significant trademark dispute in Türkiye, where courts found that a third party acted in bad faith by registering the 'Clindoxyl' mark after GSK's original registration lapsed. T... Read the full IIPLA article: https://iipla.org/news/turkish-courts-invalidate-bad-faith-clindoxyl-trademark-registration-in-favor-of-gsk

Related Coverage

Continue in the newsroom

Back to newsroom
PatentsGlobal

Nigeria Advances Intellectual Property Reforms to Boost Economic Growth and Innovation

The Nigerian Federal Government is intensifying efforts to leverage intellectual property as a catalyst for economic development, investment, and job creation. Through collaboration with the World Intellectual Property Organization (WIPO) and the rollout of the Industrial Property Administration System (IPAS), Nigeria…

Thursday, May 28, 2026
PatentsGlobal

Procopio’s Patent Practice and Five Partners Earn Spots on 2026 IAM Patent 1000 List

Procopio’s patent prosecution team and five intellectual property partners have been named to the prestigious 2026 IAM Patent 1000 list. The recognition highlights the firm’s strengths in life sciences, AI, emerging technologies, and trade secrets, underscoring its integrated approach to patent portfolio development a…

Thursday, May 28, 2026